FR2432713A1
(fr)
*
|
1978-08-02 |
1980-02-29 |
Inst Nat Sante Rech Med |
Application de la d5,3-ceto steroide isomerase dans les dosages immunoenzymatiques
|
JPS55136261A
(en)
*
|
1979-04-12 |
1980-10-23 |
Toyo Jozo Co Ltd |
Novel compound and kit comprising it
|
FR2470773B1
(nl)
*
|
1979-11-28 |
1983-01-28 |
Pasteur Institut |
|
US4318981A
(en)
*
|
1980-04-24 |
1982-03-09 |
Miles Laboratories, Inc. |
Homogeneous specific binding assay employing an intramolecularly modulated photogenic enzyme substrate label
|
SE8003732L
(sv)
*
|
1980-05-19 |
1981-11-20 |
Pharmacia Diagnostics Ab |
Sett vid bestemningsmetoder involverande biospecifika affinitetsreaktioner
|
US4486540A
(en)
*
|
1980-07-18 |
1984-12-04 |
Science Research Center, Inc. |
Identification of reagins in the blood serum of allergen sensitized vertebrates
|
US4696907A
(en)
*
|
1980-07-18 |
1987-09-29 |
Science Research Center, Inc. |
Identification of reagins in the blood serum of allergen sensitized vertebrates
|
SE8102194L
(sv)
*
|
1981-04-06 |
1982-10-07 |
Pharmacia Ab |
Terapeutiskt aktiv organisk forening och farmaceutisk beredning innehallande denna
|
SE8102193L
(sv)
*
|
1981-04-06 |
1982-10-07 |
Pharmacia Ab |
Terapeutiskt aktiv organisk forening och dess anvendning
|
US4481298A
(en)
*
|
1981-04-13 |
1984-11-06 |
Amf Incorporated |
Pre-precipitated double antibody immunoassay method
|
NL8102178A
(nl)
*
|
1981-05-02 |
1982-12-01 |
Stichting Centraal Lab |
Werkwijze voor het aantonen van tegen bepaalde antigenen gerichte antistoffen, alsmede inrichting en reagentia voor het uitvoeren van deze werkwijze.
|
FR2523445A1
(fr)
*
|
1982-03-17 |
1983-09-23 |
Sanofi Sa |
Nouveaux conjugues associant, par liaison covalente, une enzyme et un anticorps, et associations medicamenteuses utilisant lesdits conjugues
|
US4614712A
(en)
*
|
1983-02-25 |
1986-09-30 |
The Upjohn Company |
Immunoassays with luciferase labeled ligands or receptors
|
SE8302758L
(sv)
*
|
1983-05-17 |
1984-11-18 |
Pharmacia Ab |
Sett for uppspjelkning av disulfidbindningar och derigenom erhallen forening
|
US4687732A
(en)
*
|
1983-06-10 |
1987-08-18 |
Yale University |
Visualization polymers and their application to diagnostic medicine
|
GB8334499D0
(en)
*
|
1983-12-24 |
1984-02-01 |
Beecham Group Plc |
Derivatives
|
GB8400653D0
(en)
*
|
1984-01-11 |
1984-02-15 |
Beecham Group Plc |
Conjugates
|
US4665022A
(en)
*
|
1984-02-17 |
1987-05-12 |
The Regents Of The University Of California |
Bioluminescent assay reagent and method
|
DE3581210D1
(de)
*
|
1985-03-04 |
1991-02-07 |
Dana Farber Cancer Inst Inc |
Immunotoxin und herstellung.
|
US4888415A
(en)
*
|
1985-03-04 |
1989-12-19 |
Dana-Farber Cancer Institute, Inc. |
Gelonin immunotoxin
|
US4863875A
(en)
*
|
1985-08-26 |
1989-09-05 |
Gia Research Company, L.P. |
Dye labelled antibodies as reagents for use in immunoassay systems
|
FR2586813B1
(fr)
*
|
1985-08-30 |
1989-05-12 |
Inst Nat Sante Rech Med |
Supports proteiques modifies aptes a immobiliser de facon reversible des anticorps ou des substances immunologiquement actives, et leurs applications au dosage et a la purification d'antigenes ou similaires.
|
US4780421A
(en)
*
|
1986-04-03 |
1988-10-25 |
Sclavo Inc. |
Cleavable labels for use in binding assays
|
US4975532A
(en)
*
|
1986-11-28 |
1990-12-04 |
Sclavo, Inc. |
Method to derivatize dextran
|
US4959306A
(en)
*
|
1986-11-28 |
1990-09-25 |
Sclavo, Inc. |
Labeling design for a binding assay reagent
|
WO1988007200A1
(en)
*
|
1987-03-19 |
1988-09-22 |
Perry, Robert, Edward |
Monoclonal antibody conjugation
|
US5171563A
(en)
*
|
1988-09-30 |
1992-12-15 |
Neorx Corporation |
Cleavable linkers for the reduction of non-target organ retention of immunoconjugates
|
GB8927365D0
(en)
*
|
1989-12-04 |
1990-01-31 |
Ici Plc |
Reagent
|
US5324650A
(en)
*
|
1990-03-20 |
1994-06-28 |
E. I. Du Pont De Nemours And Company |
Situ process for production of conjugates
|
US6274325B1
(en)
*
|
1990-06-25 |
2001-08-14 |
Boehringer Mannheim Gmbh |
Method for carrying out a homogeneous-immunoassay based on agglutination
|
US5191066A
(en)
*
|
1990-12-07 |
1993-03-02 |
Abbott Laboratories |
Site-specific conjugation of immunoglobulins and detectable labels
|
US5470997A
(en)
*
|
1992-04-06 |
1995-11-28 |
Biosite Diagnostics Incorporated |
Amphetamine derivatives and protein and polypeptide amphetamine derivative conjugates and labels
|
EP0635019B1
(en)
*
|
1992-04-06 |
1999-05-26 |
Biosite Diagnostics Inc. |
Opiate derivatives and protein and polypeptide opiate derivative conjugates and labels
|
US5331109A
(en)
*
|
1992-04-06 |
1994-07-19 |
Biosite Diagnostics Incorporated |
Phencyclidine derivatives and protein and polypeptide phencyclidine derivative conjugates and labels
|
US6037455A
(en)
*
|
1992-11-09 |
2000-03-14 |
Biosite Diagnostics Incorporated |
Propoxyphene derivatives and protein and polypeptide propoxyphene derivative conjugates and labels
|
US5536820A
(en)
*
|
1993-02-26 |
1996-07-16 |
E. I. Du Pont De Nemours And Company |
Avidin-binding azo reagents
|
US5736624A
(en)
*
|
1994-12-02 |
1998-04-07 |
Abbott Laboratories |
Phosphatase activated crosslinking, conjugating and reducing agents; methods of using such agents; and reagents comprising phosphatase activated crosslinking and conjugating agents
|
US5795784A
(en)
|
1996-09-19 |
1998-08-18 |
Abbott Laboratories |
Method of performing a process for determining an item of interest in a sample
|
US5856194A
(en)
|
1996-09-19 |
1999-01-05 |
Abbott Laboratories |
Method for determination of item of interest in a sample
|
US20040241688A1
(en)
*
|
2001-07-19 |
2004-12-02 |
Cuneyt Bukusoglu |
Human tissue specific drug screening procedure
|
US7695752B2
(en)
|
2003-01-24 |
2010-04-13 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Target activated microtransfer
|
CA2513646C
(en)
*
|
2003-01-24 |
2013-09-17 |
Michael R. Emmert-Buck |
Target activated microtransfer
|
US20050176108A1
(en)
*
|
2003-03-13 |
2005-08-11 |
Young-Min Kim |
Physiologically active polypeptide conjugate having prolonged in vivo half-life
|
US20040180054A1
(en)
*
|
2003-03-13 |
2004-09-16 |
Hanmi Pharm. Co., Ltd. |
Physiologically active polypeptide conjugate having prolonged in vivo half-life
|
EP1877101B1
(en)
|
2005-04-28 |
2016-11-16 |
Ventana Medical Systems, Inc. |
Enzymes conjugated to antibodies via a peg heterobifuctional linker
|
EP1893241A2
(en)
*
|
2005-04-28 |
2008-03-05 |
Ventana Medical Systems, Inc. |
Fluorescent nanoparticles conjugated to antibodies via a peg linker
|
US7957466B2
(en)
*
|
2005-09-16 |
2011-06-07 |
Sony Corporation |
Adaptive area of influence filter for moving object boundaries
|
JP5199880B2
(ja)
*
|
2005-11-23 |
2013-05-15 |
ベンタナ・メデイカル・システムズ・インコーポレーテツド |
分子コンジュゲート
|
US8492098B2
(en)
|
2006-02-21 |
2013-07-23 |
The Trustees Of Tufts College |
Methods and arrays for target analyte detection and determination of reaction components that affect a reaction
|
US11237171B2
(en)
|
2006-02-21 |
2022-02-01 |
Trustees Of Tufts College |
Methods and arrays for target analyte detection and determination of target analyte concentration in solution
|
ES2556627T3
(es)
|
2007-08-30 |
2016-01-19 |
Trustees Of Tufts College |
Métodos para determinar la concentración de un analito en solución
|
US20100075439A1
(en)
*
|
2008-09-23 |
2010-03-25 |
Quanterix Corporation |
Ultra-sensitive detection of molecules by capture-and-release using reducing agents followed by quantification
|
US8222047B2
(en)
|
2008-09-23 |
2012-07-17 |
Quanterix Corporation |
Ultra-sensitive detection of molecules on single molecule arrays
|
US20100075862A1
(en)
*
|
2008-09-23 |
2010-03-25 |
Quanterix Corporation |
High sensitivity determination of the concentration of analyte molecules or particles in a fluid sample
|
US9910040B2
(en)
*
|
2012-07-09 |
2018-03-06 |
Sevident, Inc. |
Molecular nets comprising capture agents and linking agents
|
US9733242B2
(en)
*
|
2012-10-07 |
2017-08-15 |
Sevident, Inc. |
Devices for capturing analyte
|
WO2011066449A1
(en)
*
|
2009-11-24 |
2011-06-03 |
Sevident |
Devices for detection of analytes
|
US8415171B2
(en)
|
2010-03-01 |
2013-04-09 |
Quanterix Corporation |
Methods and systems for extending dynamic range in assays for the detection of molecules or particles
|
US8236574B2
(en)
|
2010-03-01 |
2012-08-07 |
Quanterix Corporation |
Ultra-sensitive detection of molecules or particles using beads or other capture objects
|
US9678068B2
(en)
|
2010-03-01 |
2017-06-13 |
Quanterix Corporation |
Ultra-sensitive detection of molecules using dual detection methods
|
WO2011109379A1
(en)
|
2010-03-01 |
2011-09-09 |
Quanterix Corporation |
Methods and systems for extending dynamic range in assays for the detection of molecules or particles
|
US9347946B2
(en)
*
|
2010-09-23 |
2016-05-24 |
Biocept, Inc. |
Methods and reagents for signal amplification
|
US9952237B2
(en)
|
2011-01-28 |
2018-04-24 |
Quanterix Corporation |
Systems, devices, and methods for ultra-sensitive detection of molecules or particles
|
WO2012142301A2
(en)
|
2011-04-12 |
2012-10-18 |
Quanterix Corporation |
Methods of determining a treatment protocol for and/or a prognosis of a patients recovery from a brain injury
|
US9932626B2
(en)
|
2013-01-15 |
2018-04-03 |
Quanterix Corporation |
Detection of DNA or RNA using single molecule arrays and other techniques
|